BR112013028095B1 - Uso de inibidores de csf-1r para o tratamento de tumores cerebrais - Google Patents

Info

Publication number

BR112013028095B1

BR112013028095B1 BR112013028095-6A BR112013028095A BR112013028095B1 BR 112013028095 B1 BR112013028095 B1 BR 112013028095B1 BR 112013028095 A BR112013028095 A BR 112013028095A BR 112013028095 B1 BR112013028095 B1 BR 112013028095B1

Authority

BR

Brazil

Prior art keywords

tumor

csf

blz945

compound

brain

Prior art date

2011-05-05

Links

• Espacenet
• Global Dossier
• Discuss

• 208000003174 Brain Neoplasms Diseases 0.000 title claims abstract description 51
• 238000011282 treatment Methods 0.000 title abstract description 77
• 239000003112 inhibitor Substances 0.000 title abstract description 32
• 150000001875 compounds Chemical class 0.000 claims abstract description 154
• 208000005017 glioblastoma Diseases 0.000 claims abstract description 88
• 150000003839 salts Chemical class 0.000 claims abstract description 31
• 206010028980 Neoplasm Diseases 0.000 claims description 132
• 206010018338 Glioma Diseases 0.000 claims description 60
• 208000032612 Glial tumor Diseases 0.000 claims description 40
• 210000004556 brain Anatomy 0.000 claims description 33
• 239000008194 pharmaceutical composition Substances 0.000 claims description 23
• 239000003795 chemical substances by application Substances 0.000 claims description 14
• 201000010915 Glioblastoma multiforme Diseases 0.000 claims description 13
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 13
• 230000001225 therapeutic effect Effects 0.000 claims description 10
• DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 claims description 8
• BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 claims description 8
• 229910052697 platinum Inorganic materials 0.000 claims description 8
• 229960004964 temozolomide Drugs 0.000 claims description 8
• 241000124008 Mammalia Species 0.000 claims description 6
• 206010027476 Metastases Diseases 0.000 claims description 6
• 238000002360 preparation method Methods 0.000 claims description 6
• 230000009401 metastasis Effects 0.000 claims description 5
• 201000004058 mixed glioma Diseases 0.000 claims description 5
• 206010003571 Astrocytoma Diseases 0.000 claims description 4
• 239000005411 L01XE02 - Gefitinib Substances 0.000 claims description 4
• 239000005551 L01XE03 - Erlotinib Substances 0.000 claims description 4
• 201000010133 Oligodendroglioma Diseases 0.000 claims description 4
• 229940100198 alkylating agent Drugs 0.000 claims description 4
• 239000002168 alkylating agent Substances 0.000 claims description 4
• 239000004037 angiogenesis inhibitor Substances 0.000 claims description 4
• 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 claims description 4
• 229960000397 bevacizumab Drugs 0.000 claims description 4
• 229930003827 cannabinoid Natural products 0.000 claims description 4
• 239000003557 cannabinoid Substances 0.000 claims description 4
• 229960005243 carmustine Drugs 0.000 claims description 4
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims description 4
• 229960004316 cisplatin Drugs 0.000 claims description 4
• AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 claims description 4
• 229960001433 erlotinib Drugs 0.000 claims description 4
• XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 claims description 4
• 229960002584 gefitinib Drugs 0.000 claims description 4
• UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims description 4
• 229960004768 irinotecan Drugs 0.000 claims description 4
• 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims description 4
• 239000005483 tyrosine kinase inhibitor Substances 0.000 claims description 4
• 206010014967 Ependymoma Diseases 0.000 claims description 3
• 229940065144 cannabinoids Drugs 0.000 claims description 3
• 238000000034 method Methods 0.000 abstract description 68
• 239000000203 mixture Substances 0.000 abstract description 28
• -1 alkyl pyrazole Chemical group 0.000 abstract description 26
• 230000004547 gene signature Effects 0.000 abstract description 8
• 125000005431 alkyl carboxamide group Chemical group 0.000 abstract description 4
• 125000005350 hydroxycycloalkyl group Chemical group 0.000 abstract description 4
• 230000002596 correlated effect Effects 0.000 abstract 1
• ADZBMFGQQWPHMJ-RHSMWYFYSA-N 4-[[2-[[(1r,2r)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-n-methylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=C3SC(N[C@H]4[C@@H](CCCC4)O)=NC3=CC=2)=C1 ADZBMFGQQWPHMJ-RHSMWYFYSA-N 0.000 description 111
• 210000004027 cell Anatomy 0.000 description 93
• 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 81
• 101710150918 Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 76
• 241000699670 Mus sp. Species 0.000 description 69
• 108090000623 proteins and genes Proteins 0.000 description 51
• 210000002540 macrophage Anatomy 0.000 description 42
• 210000001519 tissue Anatomy 0.000 description 40
• 239000003981 vehicle Substances 0.000 description 35
• 230000004083 survival effect Effects 0.000 description 34
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 33
• 239000003814 drug Substances 0.000 description 33
• 238000012706 support-vector machine Methods 0.000 description 31
• 230000014509 gene expression Effects 0.000 description 30
• 238000004458 analytical method Methods 0.000 description 29
• 230000001537 neural effect Effects 0.000 description 28
• 241000699666 Mus <mouse, genus> Species 0.000 description 27
• 230000000694 effects Effects 0.000 description 27
• 210000004881 tumor cell Anatomy 0.000 description 26
• 201000010099 disease Diseases 0.000 description 25
• 229940124597 therapeutic agent Drugs 0.000 description 25
• 241001465754 Metazoa Species 0.000 description 21
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 18
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 18
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 16
• 102100022338 Integrin alpha-M Human genes 0.000 description 16
• 201000011510 cancer Diseases 0.000 description 16
• 229910052805 deuterium Inorganic materials 0.000 description 16
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
• 210000004979 bone marrow derived macrophage Anatomy 0.000 description 15
• 239000000872 buffer Substances 0.000 description 15
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 14
• 230000008499 blood brain barrier function Effects 0.000 description 14
• 210000001218 blood-brain barrier Anatomy 0.000 description 14
• 230000001965 increasing effect Effects 0.000 description 14
• 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 13
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 13
• 238000010348 incorporation Methods 0.000 description 12
• 239000000546 pharmaceutical excipient Substances 0.000 description 12
• 230000035755 proliferation Effects 0.000 description 12
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 11
• 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 11
• 239000004480 active ingredient Substances 0.000 description 11
• 239000002246 antineoplastic agent Substances 0.000 description 11
• 239000006285 cell suspension Substances 0.000 description 11
• 229940127089 cytotoxic agent Drugs 0.000 description 11
• 230000012010 growth Effects 0.000 description 11
• 238000001727 in vivo Methods 0.000 description 11
• 230000002401 inhibitory effect Effects 0.000 description 11
• 238000012360 testing method Methods 0.000 description 11
• 230000005764 inhibitory process Effects 0.000 description 10
• 230000001404 mediated effect Effects 0.000 description 10
• 235000018102 proteins Nutrition 0.000 description 10
• 102000004169 proteins and genes Human genes 0.000 description 10
• 230000011664 signaling Effects 0.000 description 10
• 238000010186 staining Methods 0.000 description 10
• 239000003826 tablet Substances 0.000 description 10
• 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 9
• 102100025136 Macrosialin Human genes 0.000 description 9
• WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 9
• 229960004853 betadex Drugs 0.000 description 9
• 230000015572 biosynthetic process Effects 0.000 description 9
• 238000000684 flow cytometry Methods 0.000 description 9
• 238000002595 magnetic resonance imaging Methods 0.000 description 9
• 230000009467 reduction Effects 0.000 description 9
• 230000002829 reductive effect Effects 0.000 description 9
• 230000001105 regulatory effect Effects 0.000 description 9
• 208000024891 symptom Diseases 0.000 description 9
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 8
• 241000283973 Oryctolagus cuniculus Species 0.000 description 8
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 8
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
• 230000001419 dependent effect Effects 0.000 description 8
• 208000035475 disorder Diseases 0.000 description 8
• 239000002609 medium Substances 0.000 description 8
• 238000001959 radiotherapy Methods 0.000 description 8
• 102000005962 receptors Human genes 0.000 description 8
• 108020003175 receptors Proteins 0.000 description 8
• 238000002560 therapeutic procedure Methods 0.000 description 8
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
• 230000027455 binding Effects 0.000 description 7
• 230000006870 function Effects 0.000 description 7
• 238000004128 high performance liquid chromatography Methods 0.000 description 7
• 238000000338 in vitro Methods 0.000 description 7
• 238000011534 incubation Methods 0.000 description 7
• 238000002347 injection Methods 0.000 description 7
• 239000007924 injection Substances 0.000 description 7
• 208000018899 proneural glioblastoma Diseases 0.000 description 7
• 239000000725 suspension Substances 0.000 description 7
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
• 101000916629 Mus musculus Macrophage colony-stimulating factor 1 Proteins 0.000 description 6
• 108091000080 Phosphotransferase Proteins 0.000 description 6
• 230000006907 apoptotic process Effects 0.000 description 6
• 238000003556 assay Methods 0.000 description 6
• 230000008901 benefit Effects 0.000 description 6
• 230000022131 cell cycle Effects 0.000 description 6
• 102000020233 phosphotransferase Human genes 0.000 description 6
• 239000003755 preservative agent Substances 0.000 description 6
• 102000004196 processed proteins & peptides Human genes 0.000 description 6
• 108090000765 processed proteins & peptides Proteins 0.000 description 6
• 230000004044 response Effects 0.000 description 6
• 229910052717 sulfur Inorganic materials 0.000 description 6
• 238000001356 surgical procedure Methods 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 5
• 108020004414 DNA Proteins 0.000 description 5
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 5
• 239000012981 Hank's balanced salt solution Substances 0.000 description 5
• 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 5
• 239000000427 antigen Substances 0.000 description 5
• 108091007433 antigens Proteins 0.000 description 5
• 102000036639 antigens Human genes 0.000 description 5
• 239000011575 calcium Substances 0.000 description 5
• 229910052791 calcium Inorganic materials 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 238000002512 chemotherapy Methods 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 239000011777 magnesium Substances 0.000 description 5
• 229910052749 magnesium Inorganic materials 0.000 description 5
• 210000001178 neural stem cell Anatomy 0.000 description 5
• 239000008188 pellet Substances 0.000 description 5
• 229920001184 polypeptide Polymers 0.000 description 5
• 238000004393 prognosis Methods 0.000 description 5
• 230000002441 reversible effect Effects 0.000 description 5
• 239000000523 sample Substances 0.000 description 5
• 239000000243 solution Substances 0.000 description 5
• 239000002904 solvent Substances 0.000 description 5
• 239000003381 stabilizer Substances 0.000 description 5
• YFDSDPIBEUFTMI-UHFFFAOYSA-N tribromoethanol Chemical compound OCC(Br)(Br)Br YFDSDPIBEUFTMI-UHFFFAOYSA-N 0.000 description 5
• 230000004614 tumor growth Effects 0.000 description 5
• 0 *NC(c1cc(Oc2ccc3nc(NC(CCCC4)C4O)[s]c3c2)ccn1)=O Chemical compound *NC(c1cc(Oc2ccc3nc(NC(CCCC4)C4O)[s]c3c2)ccn1)=O 0.000 description 4
• 108010009992 CD163 antigen Proteins 0.000 description 4
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 241000283074 Equus asinus Species 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
• 102000003777 Interleukin-1 beta Human genes 0.000 description 4
• 108090000193 Interleukin-1 beta Proteins 0.000 description 4
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
• 108090000526 Papain Proteins 0.000 description 4
• 239000004698 Polyethylene Substances 0.000 description 4
• 239000004365 Protease Substances 0.000 description 4
• 102100025831 Scavenger receptor cysteine-rich type 1 protein M130 Human genes 0.000 description 4
• 108010056354 Ubiquitin C Proteins 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 230000033115 angiogenesis Effects 0.000 description 4
• 210000001130 astrocyte Anatomy 0.000 description 4
• 125000004429 atom Chemical group 0.000 description 4
• 239000002585 base Substances 0.000 description 4
• 210000005013 brain tissue Anatomy 0.000 description 4
• 239000002775 capsule Substances 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 238000010790 dilution Methods 0.000 description 4
• 239000012895 dilution Substances 0.000 description 4
• 239000002552 dosage form Substances 0.000 description 4
• 238000005516 engineering process Methods 0.000 description 4
• 229940088598 enzyme Drugs 0.000 description 4
• 238000010199 gene set enrichment analysis Methods 0.000 description 4
• 230000002068 genetic effect Effects 0.000 description 4
• 230000006872 improvement Effects 0.000 description 4
• 230000008595 infiltration Effects 0.000 description 4
• 238000001764 infiltration Methods 0.000 description 4
• 230000000155 isotopic effect Effects 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 239000000314 lubricant Substances 0.000 description 4
• 230000036210 malignancy Effects 0.000 description 4
• 239000000463 material Substances 0.000 description 4
• 230000011987 methylation Effects 0.000 description 4
• 238000007069 methylation reaction Methods 0.000 description 4
• 238000010172 mouse model Methods 0.000 description 4
• 210000004498 neuroglial cell Anatomy 0.000 description 4
• 229910052757 nitrogen Inorganic materials 0.000 description 4
• 229940055729 papain Drugs 0.000 description 4
• 235000019834 papain Nutrition 0.000 description 4
• 230000035515 penetration Effects 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 239000000047 product Substances 0.000 description 4
• 210000003491 skin Anatomy 0.000 description 4
• 230000000638 stimulation Effects 0.000 description 4
• 238000013517 stratification Methods 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
• 210000004981 tumor-associated macrophage Anatomy 0.000 description 4
• LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 3
• 101150096316 5 gene Proteins 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 102000004379 Adrenomedullin Human genes 0.000 description 3
• 101800004616 Adrenomedullin Proteins 0.000 description 3
• WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 3
• 206010006187 Breast cancer Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 241000283707 Capra Species 0.000 description 3
• 102000003952 Caspase 3 Human genes 0.000 description 3
• 108090000397 Caspase 3 Proteins 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
• 101710109169 Formyl peptide receptor 2 Proteins 0.000 description 3
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
• 241001529936 Murinae Species 0.000 description 3
• 102100021126 N-formyl peptide receptor 2 Human genes 0.000 description 3
• 206010061309 Neoplasm progression Diseases 0.000 description 3
• 102100037935 Polyubiquitin-C Human genes 0.000 description 3
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
• 238000011529 RT qPCR Methods 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 229920002472 Starch Polymers 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 238000001772 Wald test Methods 0.000 description 3
• 238000010521 absorption reaction Methods 0.000 description 3
• ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 description 3
• 150000001412 amines Chemical class 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• 239000007864 aqueous solution Substances 0.000 description 3
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 238000001574 biopsy Methods 0.000 description 3
• 210000004958 brain cell Anatomy 0.000 description 3
• 229950004398 broxuridine Drugs 0.000 description 3
• 238000010804 cDNA synthesis Methods 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 238000012512 characterization method Methods 0.000 description 3
• 239000000460 chlorine Substances 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 239000002299 complementary DNA Substances 0.000 description 3
• 239000003636 conditioned culture medium Substances 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 239000000796 flavoring agent Substances 0.000 description 3
• 235000003599 food sweetener Nutrition 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 239000000499 gel Substances 0.000 description 3
• 239000007903 gelatin capsule Substances 0.000 description 3
• 210000002865 immune cell Anatomy 0.000 description 3
• 238000010166 immunofluorescence Methods 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 238000011835 investigation Methods 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 230000003902 lesion Effects 0.000 description 3
• 210000000265 leukocyte Anatomy 0.000 description 3
• 230000007774 longterm Effects 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 210000004379 membrane Anatomy 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 210000000274 microglia Anatomy 0.000 description 3
• 210000004940 nucleus Anatomy 0.000 description 3
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
• 238000004806 packaging method and process Methods 0.000 description 3
• JGWRKYUXBBNENE-UHFFFAOYSA-N pexidartinib Chemical compound C1=NC(C(F)(F)F)=CC=C1CNC(N=C1)=CC=C1CC1=CNC2=NC=C(Cl)C=C12 JGWRKYUXBBNENE-UHFFFAOYSA-N 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 238000006366 phosphorylation reaction Methods 0.000 description 3
• 229910052700 potassium Inorganic materials 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 230000002285 radioactive effect Effects 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 238000002603 single-photon emission computed tomography Methods 0.000 description 3
• 239000011734 sodium Substances 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 235000019698 starch Nutrition 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 239000003765 sweetening agent Substances 0.000 description 3
• 230000000699 topical effect Effects 0.000 description 3
• 230000005751 tumor progression Effects 0.000 description 3
• 238000001262 western blot Methods 0.000 description 3
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
• 101150054329 ALOX15 gene Proteins 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
• 208000018084 Bone neoplasm Diseases 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 108010078791 Carrier Proteins Proteins 0.000 description 2
• 108091007854 Cdh1/Fizzy-related Proteins 0.000 description 2
• 108091029523 CpG island Proteins 0.000 description 2
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
• 102100030012 Deoxyribonuclease-1 Human genes 0.000 description 2
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
• 102000030782 GTP binding Human genes 0.000 description 2
• 108091000058 GTP-Binding Proteins 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 102000016761 Haem oxygenases Human genes 0.000 description 2
• 108050006318 Haem oxygenases Proteins 0.000 description 2
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
• 208000017604 Hodgkin disease Diseases 0.000 description 2
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 108010062228 Karyopherins Proteins 0.000 description 2
• 102000011781 Karyopherins Human genes 0.000 description 2
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• 101100260702 Mus musculus Tinagl1 gene Proteins 0.000 description 2
• 108700019961 Neoplasm Genes Proteins 0.000 description 2
• 102000048850 Neoplasm Genes Human genes 0.000 description 2
• 102000008730 Nestin Human genes 0.000 description 2
• 108010088225 Nestin Proteins 0.000 description 2
• 108700020796 Oncogene Proteins 0.000 description 2
• 101150038994 PDGFRA gene Proteins 0.000 description 2
• 229940122344 Peptidase inhibitor Drugs 0.000 description 2
• 206010057249 Phagocytosis Diseases 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
• 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 2
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 102100024450 Prostaglandin E2 receptor EP4 subtype Human genes 0.000 description 2
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 2
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 2
• 238000002123 RNA extraction Methods 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 102000018779 Replication Protein C Human genes 0.000 description 2
• 108010027647 Replication Protein C Proteins 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• 102100036428 Spondin-1 Human genes 0.000 description 2
• 235000021355 Stearic acid Nutrition 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 229920006362 Teflon® Polymers 0.000 description 2
• 102000044159 Ubiquitin Human genes 0.000 description 2
• 108090000848 Ubiquitin Proteins 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 210000001766 X chromosome Anatomy 0.000 description 2
• 241000269368 Xenopus laevis Species 0.000 description 2
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 210000001789 adipocyte Anatomy 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 239000000783 alginic acid Substances 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 229960001126 alginic acid Drugs 0.000 description 2
• 150000004781 alginic acids Chemical class 0.000 description 2
• 239000003963 antioxidant agent Substances 0.000 description 2
• 235000006708 antioxidants Nutrition 0.000 description 2
• 230000001640 apoptogenic effect Effects 0.000 description 2
• 101150088826 arg1 gene Proteins 0.000 description 2
• 239000007640 basal medium Substances 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 239000000090 biomarker Substances 0.000 description 2
• 229940098773 bovine serum albumin Drugs 0.000 description 2
• 229910000019 calcium carbonate Inorganic materials 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 150000003857 carboxamides Chemical class 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 210000002230 centromere Anatomy 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 230000000973 chemotherapeutic effect Effects 0.000 description 2
• 239000007979 citrate buffer Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 239000003086 colorant Substances 0.000 description 2
• 238000002648 combination therapy Methods 0.000 description 2
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• 238000012303 cytoplasmic staining Methods 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 238000009795 derivation Methods 0.000 description 2
• 150000001975 deuterium Chemical group 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 238000010201 enrichment analysis Methods 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 235000013355 food flavoring agent Nutrition 0.000 description 2
• 238000007710 freezing Methods 0.000 description 2
• 230000008014 freezing Effects 0.000 description 2
• 239000012737 fresh medium Substances 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 235000013922 glutamic acid Nutrition 0.000 description 2
• 239000004220 glutamic acid Substances 0.000 description 2
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
• 229910052737 gold Inorganic materials 0.000 description 2
• 239000010931 gold Substances 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 229940093915 gynecological organic acid Drugs 0.000 description 2
• 210000003630 histaminocyte Anatomy 0.000 description 2
• 238000003384 imaging method Methods 0.000 description 2
• 238000007654 immersion Methods 0.000 description 2
• 238000003125 immunofluorescent labeling Methods 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 239000003701 inert diluent Substances 0.000 description 2
• 150000007529 inorganic bases Chemical class 0.000 description 2
• 102000006495 integrins Human genes 0.000 description 2
• 108010044426 integrins Proteins 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 239000012139 lysis buffer Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 108020004999 messenger RNA Proteins 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 238000010208 microarray analysis Methods 0.000 description 2
• 150000007522 mineralic acids Chemical class 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 239000003068 molecular probe Substances 0.000 description 2
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
• 239000012120 mounting media Substances 0.000 description 2
• 210000000066 myeloid cell Anatomy 0.000 description 2
• 210000005055 nestin Anatomy 0.000 description 2
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
• 150000007524 organic acids Chemical class 0.000 description 2
• 235000005985 organic acids Nutrition 0.000 description 2
• 150000007530 organic bases Chemical class 0.000 description 2
• 230000000242 pagocytic effect Effects 0.000 description 2
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
• 230000010412 perfusion Effects 0.000 description 2
• 230000008782 phagocytosis Effects 0.000 description 2
• 230000036470 plasma concentration Effects 0.000 description 2
• 230000010287 polarization Effects 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 108010005636 polypeptide C Proteins 0.000 description 2
• 238000002600 positron emission tomography Methods 0.000 description 2
• 239000011591 potassium Substances 0.000 description 2
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 239000003531 protein hydrolysate Substances 0.000 description 2
• 230000008929 regeneration Effects 0.000 description 2
• 238000011069 regeneration method Methods 0.000 description 2
• 229940085606 rembrandt Drugs 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 239000007921 spray Substances 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 239000008117 stearic acid Substances 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 230000001629 suppression Effects 0.000 description 2
• 230000002195 synergetic effect Effects 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 230000009466 transformation Effects 0.000 description 2
• 229950004616 tribromoethanol Drugs 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 230000005748 tumor development Effects 0.000 description 2
• 238000012762 unpaired Student’s t-test Methods 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• 239000003643 water by type Substances 0.000 description 2
• 229910052725 zinc Inorganic materials 0.000 description 2
• 239000011701 zinc Substances 0.000 description 2
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
• BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
• LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
• IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
• LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
• WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
• SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
• 101150047313 52 gene Proteins 0.000 description 1
• 101150026888 84 gene Proteins 0.000 description 1
• 108010011122 A Kinase Anchor Proteins Proteins 0.000 description 1
• 101150017558 ACKR3 gene Proteins 0.000 description 1
• 101150014538 ACP5 gene Proteins 0.000 description 1
• 101150053137 AIF1 gene Proteins 0.000 description 1
• 101150030879 ALDH1A2 gene Proteins 0.000 description 1
• 101150073126 APOC4 gene Proteins 0.000 description 1
• 101150095401 AURKA gene Proteins 0.000 description 1
• 101150034941 AURKB gene Proteins 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 102100036664 Adenosine deaminase Human genes 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 101150028863 Akap12 gene Proteins 0.000 description 1
• 108010031132 Alcohol Oxidoreductases Proteins 0.000 description 1
• 102000005751 Alcohol Oxidoreductases Human genes 0.000 description 1
• 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
• 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 1
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 1
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
• 102100026468 Androgen-induced gene 1 protein Human genes 0.000 description 1
• 101150102415 Apob gene Proteins 0.000 description 1
• 101150007356 Apoc1 gene Proteins 0.000 description 1
• 101710095342 Apolipoprotein B Proteins 0.000 description 1
• 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
• 102000011772 Apolipoprotein C-I Human genes 0.000 description 1
• 108010076807 Apolipoprotein C-I Proteins 0.000 description 1
• 101710086822 Apolipoprotein C-IV Proteins 0.000 description 1
• 102100037322 Apolipoprotein C-IV Human genes 0.000 description 1
• 101100125452 Arabidopsis thaliana ICR1 gene Proteins 0.000 description 1
• 102000009515 Arachidonate 15-Lipoxygenase Human genes 0.000 description 1
• 108010048907 Arachidonate 15-lipoxygenase Proteins 0.000 description 1
• 102000004452 Arginase Human genes 0.000 description 1
• 102100021723 Arginase-1 Human genes 0.000 description 1
• 101710129000 Arginase-1 Proteins 0.000 description 1
• 108700024123 Arginases Proteins 0.000 description 1
• 206010003497 Asphyxia Diseases 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 108090000461 Aurora Kinase A Proteins 0.000 description 1
• 102100032311 Aurora kinase A Human genes 0.000 description 1
• 102000004228 Aurora kinase B Human genes 0.000 description 1
• 108090000749 Aurora kinase B Proteins 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
• 101150115284 BIRC5 gene Proteins 0.000 description 1
• 108091007065 BIRCs Proteins 0.000 description 1
• 102100037150 BMP and activin membrane-bound inhibitor homolog Human genes 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 101001042041 Bos taurus Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Proteins 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
• YCQXHBBFZLYHGZ-UHFFFAOYSA-N C#CCC[N+]1=CC1 Chemical compound C#CCC[N+]1=CC1 YCQXHBBFZLYHGZ-UHFFFAOYSA-N 0.000 description 1
• 108010052382 CD83 antigen Proteins 0.000 description 1
• 102100035793 CD83 antigen Human genes 0.000 description 1
• 102000009728 CDC2 Protein Kinase Human genes 0.000 description 1
• 108010034798 CDC2 Protein Kinase Proteins 0.000 description 1
• 101150047144 CDC28 gene Proteins 0.000 description 1
• 101150029001 CDH2 gene Proteins 0.000 description 1
• 101150012716 CDK1 gene Proteins 0.000 description 1
• 101150068664 CNTN1 gene Proteins 0.000 description 1
• 101150101563 COL11A1 gene Proteins 0.000 description 1
• 101150081337 CSPG5 gene Proteins 0.000 description 1
• 101150057284 CTNND2 gene Proteins 0.000 description 1
• 102000000905 Cadherin Human genes 0.000 description 1
• 108050007957 Cadherin Proteins 0.000 description 1
• 102100025805 Cadherin-1 Human genes 0.000 description 1
• 101100326430 Caenorhabditis elegans bub-1 gene Proteins 0.000 description 1
• 101100491335 Caenorhabditis elegans mat-2 gene Proteins 0.000 description 1
• 101100184147 Caenorhabditis elegans mix-1 gene Proteins 0.000 description 1
• 101100412644 Caenorhabditis elegans rfc-4 gene Proteins 0.000 description 1
• 101100095984 Caenorhabditis elegans smc-4 gene Proteins 0.000 description 1
• 102000000584 Calmodulin Human genes 0.000 description 1
• 108010041952 Calmodulin Proteins 0.000 description 1
• 102100036338 Calmodulin-like protein 4 Human genes 0.000 description 1
• 101150048961 Camkk1 gene Proteins 0.000 description 1
• 102100038781 Carbohydrate sulfotransferase 2 Human genes 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 102000016362 Catenins Human genes 0.000 description 1
• 108010067316 Catenins Proteins 0.000 description 1
• 108090000610 Cathepsin F Proteins 0.000 description 1
• 102000004176 Cathepsin F Human genes 0.000 description 1
• 101150079049 Ccnd2 gene Proteins 0.000 description 1
• 101150089199 Cd93 gene Proteins 0.000 description 1
• 101150023302 Cdc20 gene Proteins 0.000 description 1
• 102000038594 Cdh1/Fizzy-related Human genes 0.000 description 1
• 102000007768 Cellular Retinol-Binding Proteins Human genes 0.000 description 1
• 108010021988 Cellular Retinol-Binding Proteins Proteins 0.000 description 1
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
• 102100031219 Centrosomal protein of 55 kDa Human genes 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 102000009410 Chemokine receptor Human genes 0.000 description 1
• 108050000299 Chemokine receptor Proteins 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
• 229920001287 Chondroitin sulfate Polymers 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 102100022641 Coagulation factor IX Human genes 0.000 description 1
• 102000009736 Collagen Type XI Human genes 0.000 description 1
• 108010034789 Collagen Type XI Proteins 0.000 description 1
• 102100024203 Collagen alpha-1(XIV) chain Human genes 0.000 description 1
• 102000029816 Collagenase Human genes 0.000 description 1
• 108060005980 Collagenase Proteins 0.000 description 1
• 102100025877 Complement component C1q receptor Human genes 0.000 description 1
• 206010010904 Convulsion Diseases 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 101150107705 Cpa3 gene Proteins 0.000 description 1
• 108010060273 Cyclin A2 Proteins 0.000 description 1
• 108010060385 Cyclin B1 Proteins 0.000 description 1
• 108010058546 Cyclin D1 Proteins 0.000 description 1
• 108010058544 Cyclin D2 Proteins 0.000 description 1
• 102100025191 Cyclin-A2 Human genes 0.000 description 1
• 102100038254 Cyclin-F Human genes 0.000 description 1
• 229920000858 Cyclodextrin Polymers 0.000 description 1
• 101150093909 Cyp4v2 gene Proteins 0.000 description 1
• 102100028188 Cystatin-F Human genes 0.000 description 1
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
• 102000003849 Cytochrome P450 Human genes 0.000 description 1
• 108091028097 Cytoplasmic polyadenylation element Proteins 0.000 description 1
• 102100028630 Cytoskeleton-associated protein 2 Human genes 0.000 description 1
• 101710087044 Cytoskeleton-associated protein 2 Proteins 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
• AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
• 101150074155 DHFR gene Proteins 0.000 description 1
• 102000016559 DNA Primase Human genes 0.000 description 1
• 108010092681 DNA Primase Proteins 0.000 description 1
• 230000005778 DNA damage Effects 0.000 description 1
• 231100000277 DNA damage Toxicity 0.000 description 1
• 102100022307 DNA polymerase alpha catalytic subunit Human genes 0.000 description 1
• 102100029903 DNA polymerase epsilon catalytic subunit A Human genes 0.000 description 1
• 102100033587 DNA topoisomerase 2-alpha Human genes 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 101710096438 DNA-binding protein Proteins 0.000 description 1
• 101150117962 DUSP1 gene Proteins 0.000 description 1
• 101100480530 Danio rerio tal1 gene Proteins 0.000 description 1
• 102100029588 Deoxycytidine kinase Human genes 0.000 description 1
• 108010033174 Deoxycytidine kinase Proteins 0.000 description 1
• 102000016911 Deoxyribonucleases Human genes 0.000 description 1
• 108010053770 Deoxyribonucleases Proteins 0.000 description 1
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical class ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 1
• 101100300807 Drosophila melanogaster spn-A gene Proteins 0.000 description 1
• 102100036109 Dual specificity protein kinase TTK Human genes 0.000 description 1
• 102100023227 E3 SUMO-protein ligase EGR2 Human genes 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 101150059401 EGR2 gene Proteins 0.000 description 1
• 101150113190 EMP1 gene Proteins 0.000 description 1
• 101150105042 EPS8 gene Proteins 0.000 description 1
• 101150109075 Eepd1 gene Proteins 0.000 description 1
• 102000009003 Endonuclease/exonuclease/phosphatases Human genes 0.000 description 1
• 108050000992 Endonuclease/exonuclease/phosphatases Proteins 0.000 description 1
• 101710204837 Envelope small membrane protein Proteins 0.000 description 1
• 102100033183 Epithelial membrane protein 1 Human genes 0.000 description 1
• 102100025403 Epoxide hydrolase 1 Human genes 0.000 description 1
• 101710167546 Epoxide hydrolase 1 Proteins 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 102100040669 F-box only protein 32 Human genes 0.000 description 1
• 101150082967 FABP3 gene Proteins 0.000 description 1
• 101150101131 FABP7 gene Proteins 0.000 description 1
• 108010076282 Factor IX Proteins 0.000 description 1
• 108010071289 Factor XIII Proteins 0.000 description 1
• 102100037733 Fatty acid-binding protein, brain Human genes 0.000 description 1
• 102100037738 Fatty acid-binding protein, heart Human genes 0.000 description 1
• 101150073369 Fbxo32 gene Proteins 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102100031510 Fibrillin-2 Human genes 0.000 description 1
• 108010030242 Fibrillin-2 Proteins 0.000 description 1
• 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 1
• 238000000729 Fisher's exact test Methods 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 1
• 102100024185 G1/S-specific cyclin-D2 Human genes 0.000 description 1
• 102100037854 G1/S-specific cyclin-E2 Human genes 0.000 description 1
• 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 1
• 101150093612 GAP43 gene Proteins 0.000 description 1
• 101150042360 GGTA1 gene Proteins 0.000 description 1
• 101150085536 GJA1 gene Proteins 0.000 description 1
• 101150033270 Gadd45a gene Proteins 0.000 description 1
• 102000030902 Galactosyltransferase Human genes 0.000 description 1
• 108060003306 Galactosyltransferase Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 1
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102000042092 Glucose transporter family Human genes 0.000 description 1
• 108091052347 Glucose transporter family Proteins 0.000 description 1
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 101150096386 Gpm6a gene Proteins 0.000 description 1
• 101150112082 Gpnmb gene Proteins 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 108010090293 Growth Differentiation Factor 3 Proteins 0.000 description 1
• 102100035364 Growth/differentiation factor 3 Human genes 0.000 description 1
• 101150105682 HSPA1A gene Proteins 0.000 description 1
• 101150020870 HSPA1B gene Proteins 0.000 description 1
• 101710113864 Heat shock protein 90 Proteins 0.000 description 1
• 102100028006 Heme oxygenase 1 Human genes 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 101150094242 Hmgn5 gene Proteins 0.000 description 1
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
• 101000718108 Homo sapiens Androgen-induced gene 1 protein Proteins 0.000 description 1
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
• 101000740070 Homo sapiens BMP and activin membrane-bound inhibitor homolog Proteins 0.000 description 1
• 101000714684 Homo sapiens Calmodulin-like protein 4 Proteins 0.000 description 1
• 101000776447 Homo sapiens Centrosomal protein of 55 kDa Proteins 0.000 description 1
• 101000909626 Homo sapiens Collagen alpha-1(XIV) chain Proteins 0.000 description 1
• 101000933665 Homo sapiens Complement component C1q receptor Proteins 0.000 description 1
• 101000884183 Homo sapiens Cyclin-F Proteins 0.000 description 1
• 101000916688 Homo sapiens Cystatin-F Proteins 0.000 description 1
• 101000902558 Homo sapiens DNA polymerase alpha catalytic subunit Proteins 0.000 description 1
• 101000864180 Homo sapiens DNA polymerase epsilon catalytic subunit A Proteins 0.000 description 1
• 101000801505 Homo sapiens DNA topoisomerase 2-alpha Proteins 0.000 description 1
• 101000659223 Homo sapiens Dual specificity protein kinase TTK Proteins 0.000 description 1
• 101001049692 Homo sapiens E3 SUMO-protein ligase EGR2 Proteins 0.000 description 1
• 101000892323 Homo sapiens F-box only protein 32 Proteins 0.000 description 1
• 101001027674 Homo sapiens Fatty acid-binding protein, brain Proteins 0.000 description 1
• 101001027663 Homo sapiens Fatty acid-binding protein, heart Proteins 0.000 description 1
• 101000738575 Homo sapiens G1/S-specific cyclin-E2 Proteins 0.000 description 1
• 101001079623 Homo sapiens Heme oxygenase 1 Proteins 0.000 description 1
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
• 101000960234 Homo sapiens Isocitrate dehydrogenase [NADP] cytoplasmic Proteins 0.000 description 1
• 101001009683 Homo sapiens Neuronal membrane glycoprotein M6-a Proteins 0.000 description 1
• 101000609261 Homo sapiens Plasminogen activator inhibitor 2 Proteins 0.000 description 1
• 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 1
• 101001072749 Homo sapiens Post-GPI attachment to proteins factor 6 Proteins 0.000 description 1
• 101001049834 Homo sapiens Potassium channel subfamily K member 2 Proteins 0.000 description 1
• 101000945496 Homo sapiens Proliferation marker protein Ki-67 Proteins 0.000 description 1
• 101000651021 Homo sapiens Splicing factor, arginine/serine-rich 19 Proteins 0.000 description 1
• 101000633445 Homo sapiens Structural maintenance of chromosomes protein 2 Proteins 0.000 description 1
• 101000825726 Homo sapiens Structural maintenance of chromosomes protein 4 Proteins 0.000 description 1
• 101000661807 Homo sapiens Suppressor of tumorigenicity 14 protein Proteins 0.000 description 1
• 101000830894 Homo sapiens Targeting protein for Xklp2 Proteins 0.000 description 1
• 101000866298 Homo sapiens Transcription factor E2F8 Proteins 0.000 description 1
• 101000904724 Homo sapiens Transmembrane glycoprotein NMB Proteins 0.000 description 1
• 101000713613 Homo sapiens Tubulin beta-4B chain Proteins 0.000 description 1
• 101150101510 Hsp90aa1 gene Proteins 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 101150088952 IGF1 gene Proteins 0.000 description 1
• 101150027225 Il34 gene Proteins 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
• 102000004372 Insulin-like growth factor binding protein 2 Human genes 0.000 description 1
• 102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 description 1
• 102000008607 Integrin beta3 Human genes 0.000 description 1
• 108010020950 Integrin beta3 Proteins 0.000 description 1
• 102100040021 Interferon-induced transmembrane protein 1 Human genes 0.000 description 1
• 101710087399 Interferon-induced transmembrane protein 1 Proteins 0.000 description 1
• 102100040020 Interferon-induced transmembrane protein 2 Human genes 0.000 description 1
• 101710087317 Interferon-induced transmembrane protein 2 Proteins 0.000 description 1
• 102100040035 Interferon-induced transmembrane protein 3 Human genes 0.000 description 1
• 101710087316 Interferon-induced transmembrane protein 3 Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108010038498 Interleukin-7 Receptors Proteins 0.000 description 1
• 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 102100039905 Isocitrate dehydrogenase [NADP] cytoplasmic Human genes 0.000 description 1
• 101710172804 K protein Proteins 0.000 description 1
• 101150094462 KCNK2 gene Proteins 0.000 description 1
• 101150049246 KHDRBS3 gene Proteins 0.000 description 1
• YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
• 108010063296 Kinesin Proteins 0.000 description 1
• 102000010638 Kinesin Human genes 0.000 description 1
• 101150033443 Klrb1a gene Proteins 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• 239000004201 L-cysteine Substances 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 206010024264 Lethargy Diseases 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 102000003820 Lipoxygenases Human genes 0.000 description 1
• 108090000128 Lipoxygenases Proteins 0.000 description 1
• 102100026753 Lymphokine-activated killer T-cell-originated protein kinase Human genes 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 101710145006 Lysis protein Proteins 0.000 description 1
• 101150046652 M2 gene Proteins 0.000 description 1
• 210000004322 M2 macrophage Anatomy 0.000 description 1
• 206010050183 Macrocephaly Diseases 0.000 description 1
• 108010058398 Macrophage Colony-Stimulating Factor Receptor Proteins 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 108010031099 Mannose Receptor Proteins 0.000 description 1
• 102100030612 Mast cell carboxypeptidase A Human genes 0.000 description 1
• 101710119290 Mast cell carboxypeptidase A Proteins 0.000 description 1
• 102000011716 Matrix Metalloproteinase 14 Human genes 0.000 description 1
• 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 description 1
• 208000005767 Megalencephaly Diseases 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 102000002151 Microfilament Proteins Human genes 0.000 description 1
• 108010040897 Microfilament Proteins Proteins 0.000 description 1
• 108091022875 Microtubule Proteins 0.000 description 1
• 102000029749 Microtubule Human genes 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 101100270966 Mus musculus Arxes1 gene Proteins 0.000 description 1
• 101100270967 Mus musculus Arxes2 gene Proteins 0.000 description 1
• 101100438949 Mus musculus Cd83 gene Proteins 0.000 description 1
• 101100166810 Mus musculus Cenpe gene Proteins 0.000 description 1
• 101100113659 Mus musculus Clec6a gene Proteins 0.000 description 1
• 101100273318 Mus musculus Ctsf gene Proteins 0.000 description 1
• 101100443626 Mus musculus Dner gene Proteins 0.000 description 1
• 101100119835 Mus musculus Fbn2 gene Proteins 0.000 description 1
• 101100335387 Mus musculus Fpr-s1 gene Proteins 0.000 description 1
• 101100019396 Mus musculus Itgax gene Proteins 0.000 description 1
• 101100301798 Mus musculus Racgap1 gene Proteins 0.000 description 1
• 101100480538 Mus musculus Tal1 gene Proteins 0.000 description 1
• 101100462869 Mus musculus Tiparp gene Proteins 0.000 description 1
• 101100099732 Mus musculus Tmem119 gene Proteins 0.000 description 1
• 108010083674 Myelin Proteins Proteins 0.000 description 1
• 102000006386 Myelin Proteins Human genes 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• 102000015223 NK Cell Lectin-Like Receptors Human genes 0.000 description 1
• 108010039435 NK Cell Lectin-Like Receptors Proteins 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• 108010077854 Natural Killer Cell Receptors Proteins 0.000 description 1
• 102000010648 Natural Killer Cell Receptors Human genes 0.000 description 1
• 102100023206 Neuromodulin Human genes 0.000 description 1
• 101710144282 Neuromodulin Proteins 0.000 description 1
• 102100030394 Neuronal membrane glycoprotein M6-a Human genes 0.000 description 1
• 102000005665 Neurotransmitter Transport Proteins Human genes 0.000 description 1
• 108010084810 Neurotransmitter Transport Proteins Proteins 0.000 description 1
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• 108010047956 Nucleosomes Proteins 0.000 description 1
• 101000870363 Oryctolagus cuniculus Glutathione S-transferase Yc Proteins 0.000 description 1
• 208000003076 Osteolysis Diseases 0.000 description 1
• 102000016979 Other receptors Human genes 0.000 description 1
• 108010064983 Ovomucin Proteins 0.000 description 1
• 102000004316 Oxidoreductases Human genes 0.000 description 1
• 108090000854 Oxidoreductases Proteins 0.000 description 1
• 101150059463 P2RY12 gene Proteins 0.000 description 1
• 101150026239 PDPN gene Proteins 0.000 description 1
• 108010014971 PDZ-binding kinase Proteins 0.000 description 1
• 239000007990 PIPES buffer Substances 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 101150043219 POLD2 gene Proteins 0.000 description 1
• 101150100594 PRIM1 gene Proteins 0.000 description 1
• 101150090112 PTPRZ1 gene Proteins 0.000 description 1
• 101150040424 PTTG1 gene Proteins 0.000 description 1
• 239000002033 PVDF binder Substances 0.000 description 1
• 229930040373 Paraformaldehyde Natural products 0.000 description 1
• 101100312945 Pasteurella multocida (strain Pm70) talA gene Proteins 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 229940122907 Phosphatase inhibitor Drugs 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 102100026187 Placenta-specific gene 8 protein Human genes 0.000 description 1
• 101710146232 Placenta-specific gene 8 protein Proteins 0.000 description 1
• 102100039419 Plasminogen activator inhibitor 2 Human genes 0.000 description 1
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
• 102000004211 Platelet factor 4 Human genes 0.000 description 1
• 108090000778 Platelet factor 4 Proteins 0.000 description 1
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
• 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 1
• 102100037265 Podoplanin Human genes 0.000 description 1
• 101710118150 Podoplanin Proteins 0.000 description 1
• 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 102100036591 Post-GPI attachment to proteins factor 6 Human genes 0.000 description 1
• 102100023204 Potassium channel subfamily K member 2 Human genes 0.000 description 1
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
• 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 101710195838 Prostaglandin E2 receptor EP4 subtype Proteins 0.000 description 1
• 108700039882 Protein Glutamine gamma Glutamyltransferase 2 Proteins 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
• 102100038095 Protein-glutamine gamma-glutamyltransferase 2 Human genes 0.000 description 1
• 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
• 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
• 101150109738 Ptger4 gene Proteins 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• 101150077724 RAB34 gene Proteins 0.000 description 1
• 102100031535 RAD51-associated protein 1 Human genes 0.000 description 1
• 101710182832 RAD51-associated protein 1 Proteins 0.000 description 1
• 101150061360 RBP1 gene Proteins 0.000 description 1
• 102100039525 RNA polymerase-associated protein CTR9 homolog Human genes 0.000 description 1
• 101710158096 RNA polymerase-associated protein CTR9 homolog Proteins 0.000 description 1
• 102100025902 RNA-binding protein 3 Human genes 0.000 description 1
• 101710133263 RNA-binding protein 3 Proteins 0.000 description 1
• 102100037414 Rac GTPase-activating protein 1 Human genes 0.000 description 1
• 101710196218 Rac GTPase-activating protein 1 Proteins 0.000 description 1
• 102000002490 Rad51 Recombinase Human genes 0.000 description 1
• 108010068097 Rad51 Recombinase Proteins 0.000 description 1
• 102100039790 Ran-specific GTPase-activating protein Human genes 0.000 description 1
• 101100341505 Rattus norvegicus Itgad gene Proteins 0.000 description 1
• 101100083561 Rattus norvegicus Pdxp gene Proteins 0.000 description 1
• 101150113624 Rbm3 gene Proteins 0.000 description 1
• 229940127361 Receptor Tyrosine Kinase Inhibitors Drugs 0.000 description 1
• 208000007660 Residual Neoplasm Diseases 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 102000000505 Ribonucleotide Reductases Human genes 0.000 description 1
• 108010041388 Ribonucleotide Reductases Proteins 0.000 description 1
• 101150029963 Rrm2 gene Proteins 0.000 description 1
• 102000051614 SET domains Human genes 0.000 description 1
• 108700039010 SET domains Proteins 0.000 description 1
• 102100028400 SH3 domain-binding glutamic acid-rich protein Human genes 0.000 description 1
• 101710098377 SH3 domain-binding glutamic acid-rich protein Proteins 0.000 description 1
• 101150064359 SLC6A1 gene Proteins 0.000 description 1
• 101150018695 SPARCL1 gene Proteins 0.000 description 1
• 101150049992 STMN1 gene Proteins 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 108010029157 Sialic Acid Binding Ig-like Lectin 2 Proteins 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 108700015968 Slam family Proteins 0.000 description 1
• 101150033995 Slc39a4 gene Proteins 0.000 description 1
• 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 description 1
• 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 description 1
• 101150031513 Smyd2 gene Proteins 0.000 description 1
• 101150037203 Sox2 gene Proteins 0.000 description 1
• 102100027779 Splicing factor, arginine/serine-rich 19 Human genes 0.000 description 1
• 101150049022 Spon1 gene Proteins 0.000 description 1
• 101710092167 Spondin-1 Proteins 0.000 description 1
• 102100024471 Stabilin-1 Human genes 0.000 description 1
• 101710164042 Stabilin-1 Proteins 0.000 description 1
• 102100029540 Structural maintenance of chromosomes protein 2 Human genes 0.000 description 1
• 102100022842 Structural maintenance of chromosomes protein 4 Human genes 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 102100037942 Suppressor of tumorigenicity 14 protein Human genes 0.000 description 1
• 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 1
• 101150017035 TMEM163 gene Proteins 0.000 description 1
• 102100024813 Targeting protein for Xklp2 Human genes 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• 102000007591 Tartrate-Resistant Acid Phosphatase Human genes 0.000 description 1
• 108010032050 Tartrate-Resistant Acid Phosphatase Proteins 0.000 description 1
• 101150098438 Tgm2 gene Proteins 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 108010000499 Thromboplastin Proteins 0.000 description 1
• 102000002262 Thromboplastin Human genes 0.000 description 1
• 102100034838 Thymidine kinase, cytosolic Human genes 0.000 description 1
• 102000005353 Tissue Inhibitor of Metalloproteinase-1 Human genes 0.000 description 1
• 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 description 1
• 101150107801 Top2a gene Proteins 0.000 description 1
• 101710183280 Topoisomerase Proteins 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 102100033159 Transcription factor 19 Human genes 0.000 description 1
• 101710119700 Transcription factor 19 Proteins 0.000 description 1
• 102100031555 Transcription factor E2F8 Human genes 0.000 description 1
• 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
• 102100037029 Transmembrane protein 119 Human genes 0.000 description 1
• 101710170979 Transmembrane protein 119 Proteins 0.000 description 1
• 102100025764 Transmembrane protein 163 Human genes 0.000 description 1
• 101710191786 Transmembrane protein 163 Proteins 0.000 description 1
• 206010051956 Trichorhinophalangeal syndrome Diseases 0.000 description 1
• DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
• 102000011408 Tripartite Motif Proteins Human genes 0.000 description 1
• 108010023649 Tripartite Motif Proteins Proteins 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 101150089725 Tspoap1 gene Proteins 0.000 description 1
• 101150047050 Tubb4b gene Proteins 0.000 description 1
• 102100036821 Tubulin beta-4B chain Human genes 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
• 108010061610 Tva receptor Proteins 0.000 description 1
• 101150021191 UHRF1 gene Proteins 0.000 description 1
• 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
• 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
• 244000290333 Vanilla fragrans Species 0.000 description 1
• 235000009499 Vanilla fragrans Nutrition 0.000 description 1
• 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 101100111052 Xenopus laevis aurka-a gene Proteins 0.000 description 1
• 101100111053 Xenopus laevis aurka-b gene Proteins 0.000 description 1
• 101000929049 Xenopus tropicalis Derriere protein Proteins 0.000 description 1
• YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 239000002250 absorbent Substances 0.000 description 1
• 230000002745 absorbent Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 230000008649 adaptation response Effects 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• 150000003863 ammonium salts Chemical class 0.000 description 1
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000001772 anti-angiogenic effect Effects 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 230000002622 anti-tumorigenesis Effects 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 239000008135 aqueous vehicle Substances 0.000 description 1
• 229940114078 arachidonate Drugs 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 239000003855 balanced salt solution Substances 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• 150000001556 benzimidazoles Chemical class 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 238000010256 biochemical assay Methods 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 210000002798 bone marrow cell Anatomy 0.000 description 1
• 229910021538 borax Inorganic materials 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 229960003150 bupivacaine Drugs 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 235000010216 calcium carbonate Nutrition 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 108010025267 calcium-dependent protein kinase Proteins 0.000 description 1
• MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 230000009400 cancer invasion Effects 0.000 description 1
• 239000012830 cancer therapeutic Substances 0.000 description 1
• 108010017957 carbohydrate sulfotransferases Proteins 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 101150013659 ccnf gene Proteins 0.000 description 1
• 238000000423 cell based assay Methods 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 239000002771 cell marker Substances 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 238000002737 cell proliferation kit Methods 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 150000001793 charged compounds Chemical class 0.000 description 1
• 238000002038 chemiluminescence detection Methods 0.000 description 1
• 229910052801 chlorine Inorganic materials 0.000 description 1
• 229940059329 chondroitin sulfate Drugs 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 235000015165 citric acid Nutrition 0.000 description 1
• 238000013145 classification model Methods 0.000 description 1
• 230000008045 co-localization Effects 0.000 description 1
• 229940105774 coagulation factor ix Drugs 0.000 description 1
• 229940105784 coagulation factor xiii Drugs 0.000 description 1
• 229960002424 collagenase Drugs 0.000 description 1
• 230000002301 combined effect Effects 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 229940125890 compound Ia Drugs 0.000 description 1
• 238000002591 computed tomography Methods 0.000 description 1
• 230000001143 conditioned effect Effects 0.000 description 1
• 239000012050 conventional carrier Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 101150056751 cpeb1 gene Proteins 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 238000002790 cross-validation Methods 0.000 description 1
• 230000021953 cytokinesis Effects 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 101150074488 ddit4 gene Proteins 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 230000036576 dermal application Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 230000009274 differential gene expression Effects 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• 239000001177 diphosphate Substances 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 239000002612 dispersion medium Substances 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
• 229940043264 dodecyl sulfate Drugs 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 101150062366 e2f8 gene Proteins 0.000 description 1
• 210000005069 ears Anatomy 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 239000002702 enteric coating Substances 0.000 description 1
• 238000009505 enteric coating Methods 0.000 description 1
• 108010008594 epithelial membrane protein-1 Proteins 0.000 description 1
• QTTMOCOWZLSYSV-QWAPEVOJSA-M equilin sodium sulfate Chemical compound [Na+].[O-]S(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 QTTMOCOWZLSYSV-QWAPEVOJSA-M 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 238000005206 flow analysis Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• 239000011737 fluorine Substances 0.000 description 1
• 239000012458 free base Substances 0.000 description 1
• 210000005153 frontal cortex Anatomy 0.000 description 1
• 229940050411 fumarate Drugs 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 235000011087 fumaric acid Nutrition 0.000 description 1
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
• 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
• 229960001731 gluceptate Drugs 0.000 description 1
• KWMLJOLKUYYJFJ-VFUOTHLCSA-N glucoheptonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O KWMLJOLKUYYJFJ-VFUOTHLCSA-N 0.000 description 1
• 229940050410 gluconate Drugs 0.000 description 1
• 229940097042 glucuronate Drugs 0.000 description 1
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• 229940074045 glyceryl distearate Drugs 0.000 description 1
• 229940075507 glyceryl monostearate Drugs 0.000 description 1
• 208000030178 grade II glioma Diseases 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 239000007902 hard capsule Substances 0.000 description 1
• 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
• 108700038605 human Smooth muscle Proteins 0.000 description 1
• 102000043827 human Smooth muscle Human genes 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 150000002431 hydrogen Chemical class 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 238000012744 immunostaining Methods 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 230000005917 in vivo anti-tumor Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 238000009434 installation Methods 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
• JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 239000007951 isotonicity adjuster Substances 0.000 description 1
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
• 229960003299 ketamine Drugs 0.000 description 1
• 229940043355 kinase inhibitor Drugs 0.000 description 1
• 238000010983 kinetics study Methods 0.000 description 1
• 210000002415 kinetochore Anatomy 0.000 description 1
• 229940001447 lactate Drugs 0.000 description 1
• 229940099584 lactobionate Drugs 0.000 description 1
• JYTUSYBCFIZPBE-AMTLMPIISA-M lactobionate Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-M 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 210000002414 leg Anatomy 0.000 description 1
• 231100000225 lethality Toxicity 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 229940057995 liquid paraffin Drugs 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 239000003589 local anesthetic agent Substances 0.000 description 1
• 238000001325 log-rank test Methods 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 229960003646 lysine Drugs 0.000 description 1
• 208000029791 lytic metastatic bone lesion Diseases 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 229940049920 malate Drugs 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 229960003194 meglumine Drugs 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 208000004141 microcephaly Diseases 0.000 description 1
• 230000002025 microglial effect Effects 0.000 description 1
• 230000003228 microsomal effect Effects 0.000 description 1
• 210000004688 microtubule Anatomy 0.000 description 1
• 230000009456 molecular mechanism Effects 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 210000005012 myelin Anatomy 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 238000012743 neurosphere formation assay Methods 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 235000001968 nicotinic acid Nutrition 0.000 description 1
• 239000011664 nicotinic acid Substances 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 108020004707 nucleic acids Proteins 0.000 description 1
• 102000039446 nucleic acids Human genes 0.000 description 1
• 150000007523 nucleic acids Chemical class 0.000 description 1
• 210000001623 nucleosome Anatomy 0.000 description 1
• 238000011580 nude mouse model Methods 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-M octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
• 229920002113 octoxynol Polymers 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 229940049964 oleate Drugs 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 1
• 210000004248 oligodendroglia Anatomy 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 230000000771 oncological effect Effects 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 210000002997 osteoclast Anatomy 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 239000006174 pH buffer Substances 0.000 description 1
• 229920002866 paraformaldehyde Polymers 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 239000013610 patient sample Substances 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 230000000149 penetrating effect Effects 0.000 description 1
• 235000019371 penicillin G benzathine Nutrition 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
• 230000008823 permeabilization Effects 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229960005141 piperazine Drugs 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 150000003058 platinum compounds Chemical class 0.000 description 1
• 102000005162 pleiotrophin Human genes 0.000 description 1
• 108010056274 polo-like kinase 1 Proteins 0.000 description 1
• 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 238000010837 poor prognosis Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 150000003141 primary amines Chemical class 0.000 description 1
• 208000030266 primary brain neoplasm Diseases 0.000 description 1
• 238000007639 printing Methods 0.000 description 1
• 230000002250 progressing effect Effects 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 210000004129 prosencephalon Anatomy 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 238000000164 protein isolation Methods 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
• 101150059570 psmB7 gene Proteins 0.000 description 1
• 150000003217 pyrazoles Chemical class 0.000 description 1
• 125000003226 pyrazolyl group Chemical group 0.000 description 1
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 108010062212 ran-binding protein 1 Proteins 0.000 description 1
• 108700042226 ras Genes Proteins 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 239000003340 retarding agent Substances 0.000 description 1
• 230000000250 revascularization Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• MOODSJOROWROTO-UHFFFAOYSA-N salicylsulfuric acid Chemical compound OC(=O)C1=CC=CC=C1OS(O)(=O)=O MOODSJOROWROTO-UHFFFAOYSA-N 0.000 description 1
• HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
• 239000012679 serum free medium Substances 0.000 description 1
• 238000012031 short term test Methods 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 210000002027 skeletal muscle Anatomy 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• 235000010339 sodium tetraborate Nutrition 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 230000003381 solubilizing effect Effects 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 239000012192 staining solution Substances 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 229940114926 stearate Drugs 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 229940086735 succinate Drugs 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
• 229940071103 sulfosalicylate Drugs 0.000 description 1
• 229910021653 sulphate ion Inorganic materials 0.000 description 1
• 230000000475 sunscreen effect Effects 0.000 description 1
• 239000000516 sunscreening agent Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 101150115276 tal1 gene Proteins 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• 238000010998 test method Methods 0.000 description 1
• 231100001274 therapeutic index Toxicity 0.000 description 1
• 230000004797 therapeutic response Effects 0.000 description 1
• 108010036901 thymidine kinase 1 Proteins 0.000 description 1
• 210000002303 tibia Anatomy 0.000 description 1
• 101150067787 tipin gene Proteins 0.000 description 1
• 102000055046 tissue-factor-pathway inhibitor 2 Human genes 0.000 description 1
• 108010016054 tissue-factor-pathway inhibitor 2 Proteins 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 239000012443 tonicity enhancing agent Substances 0.000 description 1
• 239000012049 topical pharmaceutical composition Substances 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 229960000281 trometamol Drugs 0.000 description 1
• 231100000588 tumorigenic Toxicity 0.000 description 1
• 230000000381 tumorigenic effect Effects 0.000 description 1
• 210000000689 upper leg Anatomy 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
• 229960001600 xylazine Drugs 0.000 description 1
• 101150041456 zwilch gene Proteins 0.000 description 1